Results 81 to 90 of about 1,253,698 (305)

Data‐driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes

Molecular Oncology, EarlyView.
This study investigates gene expression differences between two major pediatric acute lymphoblastic leukemia (ALL) subtypes, B‐cell precursor ALL, and T‐cell ALL, using a data‐driven approach consisting of biostatistics and machine learning methods. Following analysis of a discovery dataset, we find a set of 14 expression markers differentiating the ...
Mona Nourbakhsh, Nikola Tom, Anna Schrøder Lassen, Helene Brasch Lind Petersen, Ulrik Kristoffer Stoltze, Karin Wadt, Kjeld Schmiegelow, Matteo Tiberti, Elena Papaleo   +8 more
wiley   +1 more source

Review of Online Evidence-based Practice Point-of-Care Information Summary Providers: Authors’ Reply to the Response by the Publisher of DynaMed

Journal of Medical Internet Research, 2010
We are pleased that the publisher of DynaMed clarified his evidence-based methodology in response to our review. We stress again how good reporting is a prerequisite for transparency.
Banzi, Rita, Liberati, Alessandro, Moschetti, Ivan, Tagliabue, Ludovica, Moja, Lorenzo   +4 more
doaj   +1 more source

Publisher's Announcements and Piracy-Monitoring Devices in Software Adoption [PDF]

, 2014
à paraître dans les Annales d'Economie et de StatistiqueInternational audienceIn this paper, we investigate the distribution strategy of a software publisher.
Darmon, Eric, Rufini, Alexandra, Torre, Dominique   +2 more
core   +2 more sources

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

Molecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo, Carlos M. Martínez‐Cáceres, Manuel Bernabé‐García, Vicente Munitiz, David Ruiz de Angulo, Pascual Parrilla, Ángeles Ortiz, Luisa F. Martínez de Haro, María L. Cayuela   +8 more
wiley   +1 more source

GIS-Publisher: Simplifying web-based GIS application development for enhanced data dissemination

SoftwareX
Geographic Information Systems (GIS) are complex systems that store, organize, process, and present geographically referenced data. Developing GIS requires specialized knowledge of algorithms, data structures, and geospatial concepts, along with the ...
Victor Lamas, David de Castro, Alejandro Cortiñas, Miguel R. Luaces   +3 more
doaj   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

The Costs and Benefits of Animal Experiments: An Evaluation with Bias. By Andrew Knight. Palgrave Macmillan: Basingstoke, Hampshire, UK, 2011; Hardcover, 272 pp; ISBN 978-0-230-57686-5; Paperback, ISBN: 978-0-230-57687-2

Animals, 2012
The book is part of the Palgrave Macmillan Animal Ethics Series which was developed with the publisher and the Oxford Centre for Animal Ethics. Andrew Knight is a Fellow of the latter. The Centre “aims to demonstrate rigorous intellectual enquiry and the
Susanne Prankel
doaj   +1 more source

Retraction of: A Routine Electroencephalography Monitoring System for Automated Sports-Related Concussion Detection (DOI: 10.1089/neur.2021.0047)

Neurotrauma Reports, 2022
The editorial leadership and publisher of Neurotrauma Reports received a formal letter from the University of Nebraska Institutional Review Board (IRB) Chairperson pertaining to the article entitled, ?A Routine Electroencephalography Monitoring System ...
doaj   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source